Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
BLRX
#4858
BioLineRX Ltd
2.380
0
USD
+2.59%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+2.59%
Aylık Değişim
-7.03%
6 aylık değişim
-15.30%
Yıllık Değişim
-15.30%
Önceki Kapanış
2.320
0
Open
2.380
0
Bid
Ask
Low
2.380
0
High
2.380
0
Hacim
1
Piyasalar
ABD Borsası
Sağlık Hizmetleri
BLRX
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
14.55 K
29.8 K
38.46 K
45.27 K
3.72 M
4.35 M
—
Valuation ratios
Enterprise value
-15.36 M
-10.56 M
-9.59 M
-1.48 M
21.42 M
13.95 M
47.68 M
Price to earnings ratio
—
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.63
0.33
0.33
0.95
0.24
0.05
—
Return on equity %
1.36
0.4
0.49
4.58
0.69
0.09
—
Return on invested capital %
—
—
—
—
—
—
—
Gross margin %
—
—
100
23.08
67.99
80.51
—
Operating margin %
—
—
4 201.3
1 035.29
70.52
871.78
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
3 595.24
1 262.79
31.86
171.69
—
Liquidity ratios
Quick ratio
—
—
—
1.47
1.56
1.78
—
Current ratio
2.15
5.91
4.87
1.53
1.76
1.95
—
Inventory turnover
—
—
—
1.89
3.63
0.09
—
Asset turnover
—
—
0.01
0.07
0.56
0.03
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
—
BioLineRx Ltd - American Depositary Shares
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.
Haberler
Hemispherian beyin kanseri ilacı GLIX1 için faz 1/2a denemesine başladı
BioLineRx Ltd. (BLRX) Q4 2025 Earnings Call Transcript
BioLineRx’in 4Ç 2025 geliri düştü, hisse senedi geriledi
BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript
BioLineRx’in 2025 3. çeyrek kazanç raporu önemli gelir kaybını ortaya koydu
Earnings call transcript: BioLineRx Q3 2025 earnings reveal significant revenue miss
BioLineRx hisseleri beklentilerin üzerindeki kazançlarla %7’den fazla yükseldi
BioLineRx shares rise over 7% on better-than-expected earnings
BioLineRx hisseleri, ortağının önemli patent izni almasıyla yükseldi
BioLineRx stock rises after partner receives key patent allowance
Hemispherian kanser ilacı GLIX1 için patent onayı aldı
Hemispherian receives patent allowance for cancer drug GLIX1